KV Pharmaceutical (ANDA) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

KV Pharmaceutical (ANDA) General Information

Description

Abbreviated New Drug Application (ANDA) for acne gel. The ANDA refers to the clindamycin phosphate (1%) and benzoyl peroxide (5%) gel, which is used for the topical treatment of inflammatory acne vulgaris.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Medical Supplies
Acquirer
Primary Office
  • 16640 Chesterfield Grove Road
  • Suite 200
  • Chesterfield, MO 63005
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KV Pharmaceutical (ANDA) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.

Request a free trial

KV Pharmaceutical (ANDA) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.

Request a free trial